Report cover image

Delfi Diagnostics Inc - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 40 Pages
SKU # GBDT21121759

Description

Summary

Delfi Diagnostics Inc (Delfi) is a biotechnology company that focuses on the early detection of cancer. It utilizes advanced machine learning algorithms and fragment omics to analyze fragments of cell-free DNA. The company's product is the FirstLook blood test, a laboratory-developed test designed to enhance lung cancer screening. Delfi products are used in the healthcare industry, particularly in routine clinical practice and large-scale clinical trials. The company operates across the US. Delfi is headquartered in Baltimore, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Delfi Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

40 Pages
Delfi Diagnostics Inc Company Overview
Delfi Diagnostics Inc Company Snapshot
Delfi Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Delfi Diagnostics Inc – Pipeline Analysis Overview
Delfi Diagnostics Inc - Key Facts
Delfi Diagnostics Inc - Major Products and Services
Delfi Diagnostics Inc Pipeline Products by Development Stage
Delfi Diagnostics Inc Ongoing Clinical Trials by Trial Status
Delfi Diagnostics Inc Pipeline Products Overview
Delfi Lung Cancer Screening Test
Delfi Lung Cancer Screening Test Product Overview
Delfi Lung Cancer Screening Test Clinical Trial
DELFI Test 01
DELFI Test 01 Product Overview
DELFI Test 01 Clinical Trial
Delfi Treatment Monitoring Test
Delfi Treatment Monitoring Test Product Overview
Hepatocellular Carcinoma Detection Test
Hepatocellular Carcinoma Detection Test Product Overview
Delfi Diagnostics Inc - Key Competitors
Delfi Diagnostics Inc - Key Employees
Delfi Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Delfi Diagnostics Inc, Recent Developments
Apr 06, 2026: DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
Dec 05, 2025: Preliminary Data from FANSS Study Show Potential for Blood-Based Lung Cancer Detection in Non-Smoking Population
Nov 04, 2025: Delphi Diagnostics Announces Four Abstracts and One General Session Presentation at the San Antonio Breast Cancer Symposium
Apr 25, 2025: Delfi Diagnostics To Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting
Nov 19, 2024: DELFI Diagnostics Selects Lahey Hospital & Medical Center to Administer New Lung Cancer Screening Test
Oct 28, 2024: Blood Test Can Monitor the Effect of Cancer Therapy
Oct 28, 2024: DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial
Oct 22, 2024: Florida Lung Health Coalition, with Support from DELFI Diagnostics, RadNet and The American Lung Association, to Launch a Revolutionary Lung Cancer Screening Program Focused on Early Detection
Oct 21, 2024: DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications
Oct 07, 2024: Allegheny Health Network Explores Use of Promising New Blood-Based Test to Enhance Lung Cancer Detection
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Delfi Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Delfi Diagnostics Inc Pipeline Products by Equipment Type
Delfi Diagnostics Inc Pipeline Products by Indication
Delfi Diagnostics Inc Ongoing Clinical Trials by Trial Status
Delfi Diagnostics Inc, Key Facts
Delfi Diagnostics Inc, Major Products and Services
Delfi Diagnostics Inc Number of Pipeline Products by Development Stage
Delfi Diagnostics Inc Pipeline Products Summary by Development Stage
Delfi Diagnostics Inc Ongoing Clinical Trials by Trial Status
Delfi Diagnostics Inc Ongoing Clinical Trials Summary
Delfi Lung Cancer Screening Test - Product Status
Delfi Lung Cancer Screening Test - Product Description
Delfi Lung Cancer Screening Test - CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
Delfi Lung Cancer Screening Test - Towards Individually Tailored Invitations, Screening Intervals and Integrated Co-morbidity Reducing Strategies in Lung Cancer Screening: 4-IN-THE-LUNG-RUN
DELFI Test 01 - Product Status
DELFI Test 01 - Product Description
DELFI Test 01 - An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of PRTH-101 Alone or in Combination with Pembrolizumab in Adults with Advanced or Metastatic Solid Tumors
Delfi Treatment Monitoring Test - Product Status
Delfi Treatment Monitoring Test - Product Description
Hepatocellular Carcinoma Detection Test - Product Status
Hepatocellular Carcinoma Detection Test - Product Description
Delfi Diagnostics Inc, Key Employees
Delfi Diagnostics Inc, Other Locations
Glossary
List of Figures
Delfi Diagnostics Inc Pipeline Products by Equipment Type
Delfi Diagnostics Inc Pipeline Products by Development Stage
Delfi Diagnostics Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us